Milnacipran

ATC N06AX17 · 7 markets · 46 records

Milnacipran 7 markets · 46 records Forms

US 25 records · 4 strengths

25 mgtabletSavella+1__no_trade__ also in CN
50 mgtabletSavella+1__no_trade__ also in CN
100 mgtabletSavella+1__no_trade__
12.5 mgtabletSavella+1__no_trade__

CN 13 records · 4 strengths

25 mgtabletManufacturer: 上海现代制药股份有限公司 ×5+2__mah__:四川科瑞德制药股份有限公司、__mah__:河北龙海药业有限公司 also in US
50 mgcapsuleManufacturer: 莹硕生技医药股份有限公司 ×4 also in TW·GB
50 mgtabletManufacturer: 上海现代制药股份有限公司 ×5 also in US
25 mgcapsuleManufacturer: 莹硕生技医药股份有限公司 ×4 also in TW

TW 2 records · 2 strengths

50 mgcapsuleMilpran Capsules 25 mg+1解鬱優膠囊50毫克 also in CN·GB
25 mgcapsuleMilpran Capsules 25 mg+1解鬱優膠囊 25 毫克 also in CN

HK 2 records · 1 strengths

Records without a stated strength · 1 Milpran Capsules 25 mg

EU 2 records · 1 strengths

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Records without a stated strength · 1 Impulsor、Milnacipran Pierre Fabre Medicament

GB 1 records · 1 strengths

50 mgcapsuleNo trade name also in CN·TW

AU 1 records · 1 strengths

Records without a stated strength · 1 Joncia

Side-by-side table

Strength / form / release	US	GB	AU	CN	TW	HK	EU
25 mg tablet	No trade name Savella	not recorded	not recorded	Manufacturer: 上海现代制药股份有限公司 ×5 Manufacturer: 四川科瑞德制药股份有限公司 ×2 Manufacturer: 河北龙海药业有限公司 ×2	not recorded	not recorded	not recorded
50 mg capsule	not recorded	No trade name	not recorded	Manufacturer: 莹硕生技医药股份有限公司 ×4	Milpran Capsules 25 mg 解鬱優膠囊50毫克	not recorded	not recorded
50 mg tablet	No trade name Savella	not recorded	not recorded	Manufacturer: 上海现代制药股份有限公司 ×5	not recorded	not recorded	not recorded
25 mg capsule	not recorded	not recorded	not recorded	Manufacturer: 莹硕生技医药股份有限公司 ×4	Milpran Capsules 25 mg 解鬱優膠囊 25 毫克	not recorded	not recorded
100 mg tablet	No trade name Savella	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
12.5 mg tablet	No trade name Savella	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
not disclosed unknown	not recorded	not recorded	Joncia	not recorded	not recorded	Milpran Capsules 25 mg	Impulsor Milnacipran Pierre Fabre Medicament

Scroll horizontally for more markets →

Each country column shows the locally registered trade names — not translations.

1 more strength/form rows are recorded only in AU · HK · EU and are not shown in this table. Hay 1 filas de concentración/forma registradas solo en AU · HK · EU que no se muestran en esta tabla. 另有 1 个规格/剂型仅在 AU · HK · EU 有记录（未在本表显示）。另有 1 個規格/劑型僅在 AU · HK · EU 有記錄（未在本表顯示）。

“not disclosed” means the source does not publish the strength — it does not mean the product has none.

Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.

Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Back to the list

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.